Industry Analysis & Industry Trends
The Veterinary Pharmaceutical Manufacturing industry is a relatively small segment of the general Australian pharmaceutical sector. The industry is involved in the development and manufacture of animal health products including veterinary medicines, vaccines, and other biological and medicinal feed additives. As such, it is geared towards two main segments: food producing animals (including cattle, pigs, poultry and sheep) and companion animals (including cats and dogs). In 2011-12, the industry accounted for just 4.4% of the overall pharmaceutical industry.
Over the five years through 2013-14, the performance of the industry was highly volatile as it contended with a number of external shocks... purchase to read more
Industry Report - Industry Key Buyers Chapter
Echoing the unprecedented degree of change currently occurring within the general pharmaceutical sector, the competitive landscape of the Veterinary Pharmaceutical Industry has undergone significant change in the five years through 2013-14. With ongoing consolidation pressures characterising the industry, this has had implications for market share concentration trends.
Following Pfizer's 2009 acquisition of Wyeth Corporation and its subsidiary Fort Dodge Animal Health, the industry underwent a significant shake up with Fort Dodge's assets being split between Pfizer and Virbac in Australia, both already major players. This resulted in an increase in concentration levels... purchase to read more